- Home
- NDRA vs BFRG Comparison
NDRA vs BFRG Comparison
Compare NDRA & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NDRA | BFRG |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 8.6M |
| IPO Year | 2016 | 2022 |
Fundamental Metrics
Financial Performance| Metric | NDRA | BFRG |
|---|---|---|
| Price | $4.54 | $0.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.3K | ★ 251.6K |
| Earning Date | 11-20-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 84.32 | 25.88 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $116,670.00 |
| Revenue This Year | N/A | $568.55 |
| Revenue Next Year | N/A | $573.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 79.49 |
| 52 Week Low | $2.96 | $0.43 |
| 52 Week High | $6.95 | $1.96 |
Technical Indicators
Market Signals| Indicator | NDRA | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 47.16 |
| Support Level | $4.28 | $0.44 |
| Resistance Level | $5.24 | $0.69 |
| Average True Range (ATR) | 0.36 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 59.41 | 62.74 |
Price Performance
Historical ComparisonAbout NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. The Company is focused specifically on advance artificial intelligence and machine learning (AI/ML)- driven analysis of complex datasets in medicine and healthcare. The Company's objective is to use its AI/ML platform to provide a precision-medicine approach to drug-asset enablement through external partnerships and selective internal development.